Psilocybin Could Help Treat Millions with Depression

Mental health is on the decline all over the world.  At the moment, nearly 264 million people are struggling with depression, for example.  To help alleviate the symptoms of depression, many turn to anti-depressants such as SSRIs (selective serotonin reuptake inhibitors). Problem is — SSRIs aren’t always useful, focusing more on symptom suppression than root … Continue reading “Psilocybin Could Help Treat Millions with Depression”

Psychedelics Could Help Treat Mental Health Issues

Psychedelics could be one of the most rewarding opportunities of 2021 and beyond.  All as countless studies show how useful they can be in treating mental health issues, such as obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, depression, and anxiety. Johns Hopkins Medicine launched the Center for Psychedelic and Consciousness Research to study compounds like LSD and … Continue reading “Psychedelics Could Help Treat Mental Health Issues”

Mental Health Embracing Psychedelic Therapies

These days, we can make a very strong case for mind-altering treatments for mental health.  Not only is the US FDA supportive of its use, but countless studies from some of the world’s leading companies are showing just how useful it can be. A study from JAMA Psychiatry just found that psilocybin “worked better than … Continue reading “Mental Health Embracing Psychedelic Therapies”

Small-Cap Pharmaceutical Stock Doubles on Positive Data

Never ignore a stock just because it appears to be down-and-out. You may just miss a triple-digit profit opportunity. Look at Axsome Therapeutics (AXSM), for example. Axsome Therapeutics is a clinical-stage biopharmaceutical company, develops therapies for the management of central nervous system (CNS) disorders. The Company’s product candidates include AXS-05 that is in Phase III … Continue reading “Small-Cap Pharmaceutical Stock Doubles on Positive Data”